logo
Plus   Neg
Share
Email

Sorrento Gets FDA Approval For Phase 1 Study For COVID Treatment; Shares Up 5%

Shares of Sorrento Therapeutics Inc. (SRNE) gained over 5% in extended trading session on Tuesday after the company FDA cleared its Investigational New Drug application for early stage study of STI-2099 in both healthy volunteers and COVID-19 patients.

Sorrento Therapeutics said it received clearance from the FDA for its Investigational New Drug application for its Phase 1 study of the safety and pharmacokinetics of intranasal STI-2099 (COVIDROPS) in both healthy volunteers and patients with mild COVID-19.

Sorrento is currently evaluating an intravenous formulation of this potent antibody, STI-2020 (IV), in a Phase 1 study in healthy volunteers and COVID-19 patients with mild symptoms.

"We plan to use our intranasal formulation technology, which allows administering a drug via simple drops in the nose, for other antibodies we are currently developing with a goal of providing coverage against all variants of the SARS-CoV-2 virus that might evade inhibition from treatment with existing therapies," said Dr. Henry Ji, Chairman and CEO of Sorrento.

SRNE closed Tuesday's trading at $9.44, down $0.81 or 7.90%, on the Nasdaq. The stock, however, gained $0.56 or 5.93% in the after-hours trade.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walmart has dropped the requirement of masks for customers and members who are fully vaccinated against COVID-19 while they are at the store. This is based on the latest guidance issued by the Centers for Disease Control and Prevention late last week. The retail giant also announced a cash bonus for all fully vaccinated associates. Amazon announced the launch of WorkingWell, a new comprehensive program providing employees with physical and mental activities, wellness exercises, and healthy eating support, across its U.S. Operations. The program has a number of components covering training and conditioning, wellness services, and technology. Each of WorkingWell's components were developed in collaboration with employees. The U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS has issued a public health alert for around 165 pounds of imported frozen Siluriformes products. The products were imported from Brazil, which is ineligible to export Siluriformes products to the United States.
RELATED NEWS
Follow RTT